A Study of Cizutamig in Systemic Sclerosis

Clinical trial NCT07158996 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07158996
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Sclerosis (SSc)

Start date: 2025-09-04
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.